BETTER THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0125 USD | +13.64% |
|
+86.57% | -93.59% |
| 05-22 | Click Therapeutics, Inc. acquired Assets of Better Therapeutics, Inc.. | CI |
| 03-21 | Better Therapeutics, Inc. Receives Notice of Default from Hercules Capital, Inc | CI |
Chart calendar Better Therapeutics, Inc.
94127d67bf6372.DSHumrMdujlHesTeg5kv9FOIqVZoucurSoT40eA2L44.QFLWt8QszXYjALCzuthXvRj8zGAZzP7Jc-_Vvrd0SeVpQr7d5V71DiRO8A~e731de97208726e31445b52295a59e61
Upcoming events on Better Therapeutics, Inc.
Past events on Better Therapeutics, Inc.
| 05/03/2024 | Advanced Technologies & Treatments for Diabetes International Conference |
| 09/11/2023 13:30 | Q3 2023 Earnings Call |
| 09/11/2023 12:00 | Q3 2023 Earnings Release |
| 30/10/2023 12:00 | Extraordinary Shareholders Meeting |
| 09/08/2023 21:30 | Q2 2023 Earnings Call |
| 09/08/2023 21:03 | Q2 2023 Earnings Release |
| 11/07/2023 13:30 | AspyreRx™ FDA Approval Call |
| 22/06/2023 | European Association for the Study of the Liver Congress - Poster Number 818 |
| 07/06/2023 17:00 | Annual General Meeting |
| 11/05/2023 13:30 | Q1 2023 Earnings Call |
| 11/05/2023 12:30 | Q1 2023 Earnings Release |
| 30/03/2023 13:30 | Q4 2022 Earnings Call |
| 30/03/2023 12:30 | Q4 2022 Earnings Release |
| 06/03/2023 16:10 | Cowen Health Care Conference |
| 13/02/2023 | BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference |
| 08/12/2022 13:30 | LivVita Study Results Call |
| 21/11/2022 19:00 | BTIG Digital Health Forum |
| 14/11/2022 21:30 | Q3 2022 Earnings Call |
| 14/11/2022 21:01 | Q3 2022 Earnings Release |
| 20/09/2022 19:45 | LifeSci Partners HealthTech Symposium |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -30,6 -28,3 -7.8% | -38,3 -41,3 7.28% | -27,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -40,5 -34,8 -16.51% | -39,8 -42,7 6.89% | -28,7 |
|
Net income Million USD | Released Forecast Spread | -6,39 | -40,3 -34,8 -16.07% | -39,8 -42,7 6.88% | -28,7 |
|
EPS USD | Released Forecast Spread | -2,05 | -3,11 -1,47 -111.56% | -1,69 -1,81 6.63% | -0,81 |
| Announcement Date | 23/04/21 | 28/03/22 | 30/03/23 | - |
Quarterly results
| Fiscal Period | December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -0,24 -8,53 97.18% | -12,1 -9,50 -27.41% | -9,35 -10,9 14.27% | -9,60 -11,7 17.87% | -11,0 -11,3 2.71% | -8,32 -11,3 26.65% | -8,93 -26,3 66.05% | -7,03 -7,09 0.89% | -5,34 -7,10 24.77% | -5,80 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -0,24 -9,46 97.47% | -13,9 -8,01 -73.52% | -9,66 -11,1 12.95% | -9,93 -11,9 16.57% | -11,4 -11,6 1.35% | -8,76 -11,7 25.11% | -9,36 -8,60 -8.79% | -7,59 -7,40 -2.51% | -5,86 -7,30 19.74% | -5,90 |
|
Net income Million USD | Released Forecast Spread | -0,24 -9,86 97.58% | -13,9 -8,13 -70.81% | -9,66 -11,1 12.95% | -9,93 -11,9 16.57% | -11,4 -11,6 1.32% | -8,77 -11,7 25.08% | -9,36 -8,60 -8.8% | -7,59 -7,40 -2.52% | -5,86 -7,30 19.7% | -5,90 |
|
EPS USD | Released Forecast Spread | -0,03 -1,87 98.4% | -0,71 -0,35 -102.86% | -0,41 -0,39 -6.49% | -0,42 -0,42 0% | -0,48 -0,45 -6.67% | -0,37 -0,50 26% | -0,39 -0,31 -27.87% | -0,24 -0,31 23.2% | -0,15 -0,20 23.08% | -0,12 |
| Announcement Date | 23/11/21 | 28/03/22 | 13/05/22 | 11/08/22 | 14/11/22 | 30/03/23 | 11/05/23 | 09/08/23 | 09/11/23 | - |
| 15/07/2024 06:45 | ADDLIFE AB: Q2 2024 Earnings Release |
| 21/07/2024 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release |
| 23/07/2024 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
| 23/07/2024 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | LONZA GROUP AG: Q2 2024 Earnings Release |
| 25/07/2024 06:00 | BACHEM HOLDING AG: Q2 2024 Earnings Release |
| 25/07/2024 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
| 26/07/2024 06:00 | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for Better Therapeutics, Inc.
| 07/06/2024 07:57 | POLARIS GROUP: May 2024 Sales and Revenue Release |
| 29/05/2024 21:01 | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
| 23/05/2024 12:00 | CUREVAC N.V.: Q1 2024 Earnings Release |
| 22/05/2024 06:00 | EVOTEC SE: Q1 2024 Earnings Release |
| 21/05/2024 22:14 | ALVOTECH: Q1 2024 Earnings Release |
| 21/05/2024 12:00 | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 17/05/2024 07:00 | BIOARCTIC AB: Q1 2024 Earnings Release |
| 15/05/2024 21:05 | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 15/05/2024 12:00 | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 14/05/2024 | GNI GROUP LTD.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BTTX Stock
- Calendar Better Therapeutics, Inc.
